Li Zhou
8PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 25, 2025
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.Li Zhou, Milton Jose Barros E Silva, Edward Hsiao
|Feb 06, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights.Xuan Wang, Hui Tian, Zhihong Chi
|Oct 17, 2024
Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma.Bixia Tang, Jun Xiao, Zhihong Chi
|Aug 20, 2024
Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatment.Li Zhou, Min Cao, Haibin Zhu
|Mar 27, 2023
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population.Li Zhou, Zhiting Shao, Yiqiang Liu
Pageof 2